Cargando…
Developing a machine learning model to identify protein–protein interaction hotspots to facilitate drug discovery
Throughout the history of drug discovery, an enzymatic-based approach for identifying new drug molecules has been primarily utilized. Recently, protein–protein interfaces that can be disrupted to identify small molecules that could be viable targets for certain diseases, such as cancer and the human...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727375/ https://www.ncbi.nlm.nih.gov/pubmed/33354416 http://dx.doi.org/10.7717/peerj.10381 |